A detailed history of Quest Partners LLC transactions in Surmodics Inc stock. As of the latest transaction made, Quest Partners LLC holds 14,982 shares of SRDX stock, worth $568,117. This represents 0.04% of its overall portfolio holdings.

Number of Shares
14,982
Previous 7,583 97.57%
Holding current value
$568,117
Previous $232 Million 92.27%
% of portfolio
0.04%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025

BUY
$26.76 - $31.1 $197,997 - $230,108
7,399 Added 97.57%
14,982 $445 Million
Q1 2025

May 14, 2025

BUY
$26.71 - $39.71 $202,541 - $301,120
7,583 New
7,583 $232 Million
Q3 2024

Nov 07, 2024

BUY
$38.47 - $42.24 $41,201 - $45,239
1,071 Added 107100.0%
1,072 $41.6 Million
Q2 2024

Aug 06, 2024

BUY
$25.39 - $42.1 $25 - $42
1 New
1 $42,000
Q4 2023

Feb 09, 2024

BUY
$28.47 - $38.49 $711 - $962
25 New
25 $909,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $531M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.